Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Hospitaler/afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Søg efter ekspertise, navn eller tilknytning
Nina Kimer
MD PhD
,
Amager og Hvidovre Hospital
,
Gastroenheden AHH
Amager og Hvidovre Hospital
,
Gastromedicinsk Afd.
2012
2024
Publikationer pr. år
Vis
Fingeraftryk
Netværk
Publikationer
(57)
Lignende profiler
(12)
Fingeraftryk
Dyk ned i forskningsemnerne, hvor Nina Kimer er aktive. Disse emneetiketter kommer fra dennes persons arbejder. Sammen danner de et unikt fingerprint.
Sorter
Vægt
Alfabetisk
Keyphrases
Cirrhosis
100%
Rifaximin
26%
Decompensated Cirrhosis
26%
Ascites
20%
Liver Cirrhosis
19%
Hepatic Encephalopathy
19%
Portal Hypertension
18%
Randomized Placebo-controlled Trial
15%
Beta-blockers
11%
Inflammation
10%
Liver
10%
Umbilical Hernia Repair
9%
Refractory Ascites
9%
Inflammation Markers
8%
Hospitalization
8%
Systematic Meta-analysis
7%
Metabolic-associated Fatty Liver Disease (MAFLD)
7%
COVID-19
7%
Acute-on-chronic Liver Failure
7%
Atorvastatin
7%
Systemic Inflammation
7%
Portal Pressure
6%
PleurX
6%
Chronic Liver Disease
6%
Disease Progression
6%
Confidence Interval
6%
Randomized Clinical Trial
6%
Prospective Cohort Study
5%
Bacterial Translocation
5%
Treatment Complications
5%
Large-volume Paracentesis
5%
Medicine and Dentistry
Liver Cirrhosis
87%
Ascites
20%
Rifaximin
19%
Hepatic Encephalopathy
19%
Decompensated Liver Cirrhosis
18%
Portal Hypertension
15%
Placebo
12%
Systematic Review
11%
Umbilical Hernia
11%
Hernioplasty
10%
Meta-Analysis
8%
Hemodynamic
8%
Beta Adrenergic Receptor Blocking Agent
8%
Cohort Analysis
8%
Liver Disease
7%
COVID-19
7%
Chronic Liver Disease
6%
Symptom
6%
Beta Adrenergic Receptor Blocking
6%
Paracentesis
6%
Spontaneous Bacterial Peritonitis
6%
Complication of Treatment
5%
Portal Venous Pressure
5%
Disease Exacerbation
5%
Bacterial Translocation
5%
Randomized Controlled Trial
5%
Hepatocellular Carcinoma
5%
Ammonium
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
74%
Rifaximin
26%
Inflammation
19%
Hepatic Encephalopathy
19%
Portal Hypertension
17%
Ascites
16%
Placebo
13%
Beta Adrenergic Receptor Blocking Agent
12%
Decompensated Liver Cirrhosis
10%
Liver Disease
10%
Acute on Chronic Liver Failure
7%
Disease
7%
Ammonium
7%
Fibrosis
5%
Anti-Inflammatory Drug
5%
